|
Market Closed -
Bombay S.E.
06:02:22 2026-10-12 EDT
|
5-day change | 1st Jan Change | ||
| 414.15 INR | +0.25% |
|
-0.25% | +0.56% |
| 09-30 | Aarti Drugs Limited Announces Relinquishment of Adhish P. Patil as Chief Financial Officer, Effective September 30, 2026 | CI |
| 09-26 | Aarti Drugs Limited Announces Board Appointments | CI |
| Market Cap | 37.8B 395M 354M 329M 299M 564M 567M 3.96B 1.55B 19.47B 1.48B 1.45B 62.62B | P/E 2027 * |
-
| P/E 2028 * | 14.8x |
|---|---|---|---|---|---|
| Enterprise Value | 37.8B 395M 354M 329M 299M 564M 567M 3.96B 1.55B 19.47B 1.48B 1.45B 62.62B | EV / Sales 2027 * |
1.28x | EV / Sales 2028 * | 1.16x |
| Free-Float |
40.44% | Yield 2027 * |
1.42% | Yield 2028 * | 1.69% |
| Markets | Quality | ||
|---|---|---|---|
Bombay S.E.
| AARTIDRUGS | Delayed | |
NSE India S.E.
| AARTIDRUGS | Delayed |
Last Transcript: Aarti Drugs Limited
| 22-12-28 | Aarti Drugs : Loss of Share Certificates | PU |
| 22-07-10 | Aarti Drugs : Newspaper Advertisements | PU |
| 1 day | +0.25% | ||
| 1 week | -0.25% | ||
| Current month | -3.81% | ||
| 1 month | -3.32% | ||
| 3 months | +4.48% | ||
| 6 months | +16.74% | ||
| Current year | +0.56% |
| 1 week | 410 |  | 432.45 |
| 1 month | 410 | | 449.9 |
| Current year | 318.6 | | 453.2 |
| 1 year | 318.6 | | 533.6 |
| 3 years | 312.5 | | 634.9 |
| 5 years | 310.8 | | 645 |
| 10 years | 104.82 | | 1,025 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 80 | - | |
| Chief Tech/Sci/R&D Officer | - | - | |
| Compliance Officer | - | 2019-04-22 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 63 | 2007-05-31 | |
| Chairman | 80 | - | |
| Director/Board Member | 63 | 1987-01-01 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.25% | -0.25% | -19.95% | -20.35% | 390M | |
| +0.28% | +3.46% | +41.89% | +93.71% | 1,051B | |
| +0.88% | +4.27% | +38.28% | +68.70% | 630B | |
| +1.68% | +5.78% | +21.96% | +89.56% | 489B | |
| -0.10% | +4.24% | +69.15% | +40.41% | 359B | |
| +0.61% | +3.18% | +24.05% | +42.46% | 344B | |
| +0.72% | +2.99% | +14.29% | +34.71% | 272B | |
| +0.23% | +2.23% | -5.91% | +8.15% | 246B | |
| +0.65% | +3.62% | +43.93% | +46.50% | 224B | |
| -0.49% | +4.01% | +28.38% | +95.97% | 187B | |
| Average | +0.41% | +2.36% | +25.61% | +49.98% | 380.41B | |
| Weighted average by Cap. | +0.46% | +2.93% | +34.07% | +66.92% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 29.45B 308M 276M 257M 233M 439M 442M 3.08B 1.21B 15.17B 1.16B 1.13B 48.79B | 32.69B 341M 306M 285M 258M 488M 491M 3.42B 1.34B 16.83B 1.28B 1.25B 54.15B |
| Net income | 2.15B 22.47M 20.14M 18.74M 17.02M 32.1M 32.3M 225M 88.25M 1.11B 84.4M 82.53M 3.56B | 2.55B 26.59M 23.83M 22.17M 20.13M 37.98M 38.21M 267M 104M 1.31B 99.85M 97.64M 4.22B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-12 | ₹414.15 | +0.25% | 5,868 |
| 26-10-09 | ₹413.10 | -0.46% | 2,781 |
| 26-10-08 | ₹415.00 | -0.42% | 13,641 |
| 26-10-07 | ₹416.75 | -2.73% | 5,924 |
| 26-10-06 | ₹428.45 | +3.19% | 15,138 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Annual profits - Rate of surprise
- Stock Market
- Stocks
- AARTIDRUGS Stock
Select your edition
All financial news and data tailored to specific country editions
